Company: OnKure Therapeutics, Inc.

Form Type: 8-K

Filing Date: 2024-10-08

Corporate Action: Spin-off

Type: New

Accession Number: 000119312524234487

Comments: The document is about a merger between Reneo Pharmaceuticals, Inc. and OnKure, Inc. and the resulting formation of a combined company named OnKure Therapeutics, Inc., rather than a spin-off.

Document Link: View Document